Academic Multicenter Prospective Observational Study of the Factors Responsible for Nephropathy in Patients With Sickle Cell Disease Followed by Belgium and the Nord-Pas -De- Calais Region and Creating a Biobank of Blood and Urine

About the study

The objective of the study is to refine our knowledge on the physiopathology of the symptoms
and the complications for the patients affected by a drepanocytic syndrome.

The establishment of risk factors and indicators of severity will allow to target better the
patients requiring an adequate strategy in order to prevent the installation of some
complications or to limit their worsening.

Study point of contact

Jonathan JB Brauner, Md
+32 02 555 34 27 ext 3427
[email protected]
Béatrice BG Gulbis, Phd MD
+32 02 555 34 27 ext 3427
[email protected]

Locations

1 Belgium site

Age

> 17 Years

Study type

Observational

Gender

All

Interventions

Genetic

Compensation

Unknown

participation requirements

– Patients 18 years or older with sickle cell syndrome

– Signing an inform consent form after validation on it by the Ethics Committees of the
participating centers.

participation restrictions

– Any pathology concomitant risk of nephropathy

– Severe CVO within the month preceding the sampling

– Transfusions within 3 months prior to sampling

– Pregnant patient or within 3 months post- accouhcement

Locations

  • Brussels, Belgium, Erasme Hospital, 1070 [Recruiting]
Last updated 2019-12-17